CAI
Caris Life Sciences
138 hedge funds and large institutions have $3.41B invested in Caris Life Sciences in 2025 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 45 increasing their positions, 19 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
17% more capital invested
Capital invested by funds: $2.92B → $3.41B (+$488M)
1.77% more ownership
Funds ownership: 38.56% → 40.33% (+1.8%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
138
Holding in Top 10
5
Calls
$12.3M
Puts
$1.65M
Top Buyers
| 1 | +$41.9M | |
| 2 | +$30.3M | |
| 3 | +$25.7M | |
| 4 |
Morgan Stanley
New York
|
+$22.1M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$21.9M |
Top Sellers
| 1 | -$47.6M | |
| 2 | -$26.7M | |
| 3 | -$15.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$9.38M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.13M |
